Form D · Biotechnology

Visterra, Inc.

Cambridge, MA · CIK 0001426375

Offering snapshot reported Dec 2, 2013 · SEC filing

Reported sold
$34.2M
Offering amount: $34.2M
Investors reported
16
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
May 14, 2012
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$17.1M$34.2MMay 25, 2012: $12,906,300.00May 25, 2012Nov 19, 2012: $26,099,699.00Nov 19, 2012Dec 2, 2013: $34,229,999.00Dec 2, 2013

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$26,099,699 → $34,229,999
  • Reported investors11 → 16

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Dec 2, 2013Amendment$34,229,999$8,130,300vs Nov 19, 201216SEC filing
Nov 19, 2012Amendment$26,099,699$13,193,399vs May 25, 201211SEC filing
May 25, 2012Initial$12,906,300No comparison8SEC filing
Sep 17, 2010Initial$6,000,000No comparison7SEC filing
Dec 8, 2009Initial$3,200,000No comparison7SEC filing
Feb 4, 2008PaperNot reportedNo comparisonNot reportedSEC filing

Offering details

Securities
Equity, Option to acquire
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-178849

Source: Form D, filed Dec 2, 2013. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
David Arkowitz Executive
Kevin Bitterman Director
Steven Brugger Director, Executive
Alan Crane Director
Edward Kania Director
Brian J.G. Pereira, M.D. Director, Executive
Ram Sasisekharan Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:
One Kendall Square Suite B3301
Cambridge, MA, 02139